ArticlebioRxiv : the preprint server for biology2025
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting.
P Yadollahi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.